|Bid||62.14 x 300|
|Ask||62.16 x 200|
|Day's range||60.56 - 62.23|
|52-week range||52.54 - 65.68|
|PE ratio (TTM)||-18.16|
|Forward Dividend & Yield||0.35 (0.59%)|
|1y target est||N/A|
DENTSPLY SIRONA's (XRAY) renewed distribution deal will aid the company to gain market traction. However, forex woes remain a concern.
This firm's move to bolster growth via a large acquisition recently resulted in the ouster of top executives. Despite pending new leadership, investors remain at risk given the firm's falling profits, lagging margins and overvalued stock price.
Directors of Dentsply Sirona forced out its chairman, CEO and president after a $14.5 billion merger completed last year ran into trouble, according to a person familiar with the matter.
Dental-products and equipment maker Dentsply Sirona said its CEO, chief operating officer and executive chairman have all resigned. The changes come less than two months after the company said it is cooperating ...
Shareholders of dental products maker Dentsply Sirona have heard it before and weren’t in a trusting mood Monday. The company’s shares plunged by as much as 8%. Dentsply's chief executive officer, chief ...
Dentsply Sirona Inc. announced Monday sweeping leadership changes, as Chief Executive Jeffrey Slovin, Executive Chairman Bret Wise and Chief Operating Officer Christopher Clark have all resigned. The dental ...